Olema Pharmaceuticals, Inc.OLMANASDAQ

Revenue (LTM)

Net Income (LTM)

$-162M

-25.5% YoY

Free Cash Flow

$-147M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	0
Operating Income	-71	-107↓49.7%	-105↑1.9%	-142↓35.5%	-179↓25.6%
Net Income	-71	-105↓47.4%	-97↑7.8%	-129↓34.0%	-162↓25.5%
EBITDA	-71	-107↓49.5%	-105↑1.9%	-142↓35.6%	-178↓25.6%
EPS Diluted	-1.79	-2.62↓46.4%	-2.14↑18.3%	-2.20↓2.8%	-1.87↑15.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	14	24↑71.6%	69↑189.2%	139↑103.5%	48↓65.4%
Total Current Assets	291	209↓28.1%	267↑27.6%	438↑64.5%	515↑17.6%
Total Assets	296	216↓27.1%	277↑28.4%	451↑62.8%	533↑18.3%
Total Current Liabilities	9	17↑83.5%	22↑30.6%	42↑93.1%	52↑24.1%
Total Liabilities	11	18↑59.1%	23↑27.4%	42↑82.3%	55↑30.6%
Total Equity	285	198↓30.6%	254↑28.5%	409↑61.1%	479↑17.0%
Total Debt	3	3↓22.0%	2↓5.8%	1↓40.9%	1↓16.5%
Net Debt	-11	-21↓100.9%	-66↓212.8%	-138↓108.8%	-47↑65.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-51	-82↓61.9%	-84↓2.0%	-104↓24.6%	-147↓40.6%
Capital Expenditure	-2	-0↑77.0%	0	-0	0
Free Cash Flow	-52	-82↓57.7%	-84↓1.6%	-105↓24.8%	-147↓40.4%
Stock-Based Comp	0	0	17	23↑30.9%	18↓22.1%
Net Change in Cash	-325	10↑103.0%	45↑353.4%	71↑58.2%	-91↓228.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance